Envestnet Asset Management Inc. raised its holdings in GE HealthCare Technologies Inc. (NASDAQ:GEHC – Free Report) by 6.8% during the 2nd quarter, according to the company in its most recent filing with the Securities & Exchange Commission. The institutional investor owned 979,031 shares of the company’s stock after acquiring an additional 61,935 shares during the period. Envestnet Asset Management Inc. owned approximately 0.21% of GE HealthCare Technologies worth $76,286,000 at the end of the most recent reporting period.
Other large investors have also recently modified their holdings of the company. Pathway Financial Advisers LLC bought a new position in shares of GE HealthCare Technologies in the 1st quarter worth $25,000. BNP Paribas purchased a new position in GE HealthCare Technologies in the first quarter worth $30,000. Sachetta LLC purchased a new stake in GE HealthCare Technologies during the fourth quarter valued at about $31,000. Rise Advisors LLC lifted its stake in GE HealthCare Technologies by 241.4% during the first quarter. Rise Advisors LLC now owns 338 shares of the company’s stock worth $31,000 after purchasing an additional 239 shares during the last quarter. Finally, Riverview Trust Co purchased a new position in shares of GE HealthCare Technologies in the 1st quarter worth about $31,000. Institutional investors own 82.06% of the company’s stock.
GE HealthCare Technologies Price Performance
Shares of NASDAQ:GEHC opened at $86.79 on Wednesday. The company has a debt-to-equity ratio of 1.05, a quick ratio of 0.82 and a current ratio of 1.06. The firm has a market cap of $39.62 billion, a price-to-earnings ratio of 25.38, a P/E/G ratio of 3.26 and a beta of 1.17. The firm has a fifty day moving average price of $83.26 and a 200 day moving average price of $83.31. GE HealthCare Technologies Inc. has a fifty-two week low of $62.35 and a fifty-two week high of $94.50.
GE HealthCare Technologies Announces Dividend
The business also recently declared a quarterly dividend, which was paid on Thursday, August 15th. Investors of record on Friday, July 19th were given a $0.03 dividend. The ex-dividend date of this dividend was Friday, July 19th. This represents a $0.12 dividend on an annualized basis and a yield of 0.14%. GE HealthCare Technologies’s dividend payout ratio is presently 3.51%.
Analyst Ratings Changes
A number of research analysts have commented on GEHC shares. Redburn Atlantic upgraded shares of GE HealthCare Technologies to a “strong-buy” rating in a research report on Thursday, August 1st. JPMorgan Chase & Co. assumed coverage on shares of GE HealthCare Technologies in a report on Monday, September 9th. They set a “neutral” rating and a $90.00 target price on the stock. Stifel Nicolaus started coverage on shares of GE HealthCare Technologies in a research note on Tuesday, August 6th. They issued a “buy” rating and a $100.00 price target for the company. Finally, The Goldman Sachs Group started coverage on GE HealthCare Technologies in a research note on Thursday, May 30th. They set a “neutral” rating and a $87.00 price objective on the stock. Six research analysts have rated the stock with a hold rating, six have assigned a buy rating and one has given a strong buy rating to the company. According to data from MarketBeat, GE HealthCare Technologies currently has an average rating of “Moderate Buy” and a consensus price target of $94.58.
Check Out Our Latest Research Report on GEHC
Insiders Place Their Bets
In related news, CEO Thomas J. Westrick sold 2,750 shares of GE HealthCare Technologies stock in a transaction dated Wednesday, August 7th. The shares were sold at an average price of $80.78, for a total transaction of $222,145.00. Following the completion of the transaction, the chief executive officer now directly owns 17,509 shares of the company’s stock, valued at approximately $1,414,377.02. The transaction was disclosed in a filing with the SEC, which is available through the SEC website. 0.27% of the stock is owned by insiders.
GE HealthCare Technologies Company Profile
GE HealthCare Technologies Inc engages in the development, manufacture, and marketing of products, services, and complementary digital solutions used in the diagnosis, treatment, and monitoring of patients in the United States, Canada, and internationally. The company operates through four segments: Imaging, Ultrasound, Patient Care Solutions, and Pharmaceutical Diagnostics.
Featured Articles
- Five stocks we like better than GE HealthCare Technologies
- Best Stocks Under $10.00
- Galmed Pharmaceuticals Surges 400%: What’s Behind the Explosion?
- Transportation Stocks Investing
- Gold Hits New All-Time Highs: 3 Stocks to Ride the Surge
- Insider Buying Explained: What Investors Need to Know
- Intel: Why It’s Time to Reconsider This Beaten-Down Chipmaker
Want to see what other hedge funds are holding GEHC? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for GE HealthCare Technologies Inc. (NASDAQ:GEHC – Free Report).
Receive News & Ratings for GE HealthCare Technologies Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for GE HealthCare Technologies and related companies with MarketBeat.com's FREE daily email newsletter.